Search

everythinglearnresearchcommunity

for

Search:↓

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Laser hair reduction near the eyebrows can cause serious eye injuries even with safety measures.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Radiation mainly affects keratinocyte stem cells, not melanocyte stem cells, causing hair to gray.

Small changes in hormones can significantly impact health, showing the importance of sensitive testing for chemicals that disrupt hormones.

The 3D scaffold helped maintain hair cell traits and could improve hair loss treatments.

Gata6 is important for protecting hair growth cells from DNA damage and keeping normal hair growth.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

COVID-19 may cause early hair loss similar to classic temporary hair loss, with further research needed.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Sp6 promotes tooth development by reducing follistatin levels.

Three white adults had a rare scalp condition with increased fat and sometimes hair loss, suggesting it's not limited to black women and might be more widespread.

Grey hair and baldness may be linked to COVID-19 severity, but more analysis is needed; post-infectious hair loss is related to the severity of the disease and usually recovers within 3-6 months.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Every elderly patient had at least one skin condition, often linked to other diseases, highlighting the need for integrated skin and general healthcare in the elderly.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Autoimmune liver diseases are likely linked to certain skin conditions like vitiligo and psoriasis.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

Ozone therapy might improve cancer treatment and reduce its side effects.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.